Minocycline hydrochloride capsules

DRUG2 trials

Sponsors

Journey Medical Corporation, Beijing Tiantan Hospital

Conditions

Intracerebral HemorrhageRosacea

Phase 1

Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks

CompletedNCT05597462

Journey Medical CorporationRosacea

Start: 2022-09-30End: 2023-05-30Updated: 2023-08-02

Phase 3

Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

Not yet recruitingNCT07338175

Beijing Tiantan HospitalIntracerebral Hemorrhage

Start: 2026-01-31End: 2028-12-31Target: 1192Updated: 2026-01-13